FB849

· 1ST Biotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FB849, covering 2025-08-17 to 2025-08-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849 [Phase 1, Phase 2]

See pricing